title: Summary of suspected adverse events, 2014.
abstract: The following article has been produced by the pharmacovigilance unit at the Veterinary Medicines Directorate (VMD) to provide a summary of some of the results from its surveillance work carried out in 2014.
authors.affiliation: Pharmacovigilance Unit, Veterinary Medicines Directorate, Woodham Lane, New Haw, Surrey KT15 3LS, e-mail: adverse.events@vmd.defra.gsi.gov.uk.
authors.forename: G
authors.initials: G
authors.lastname: Davis
authors.affiliation: Pharmacovigilance Unit, Veterinary Medicines Directorate, Woodham Lane, New Haw, Surrey KT15 3LS, e-mail: adverse.events@vmd.defra.gsi.gov.uk.
authors.forename: S
authors.initials: S
authors.lastname: Cooles
authors.affiliation: Pharmacovigilance Unit, Veterinary Medicines Directorate, Woodham Lane, New Haw, Surrey KT15 3LS, e-mail: adverse.events@vmd.defra.gsi.gov.uk.
authors.forename: G
authors.initials: G
authors.lastname: Diesel
authors.affiliation: Pharmacovigilance Unit, Veterinary Medicines Directorate, Woodham Lane, New Haw, Surrey KT15 3LS, e-mail: adverse.events@vmd.defra.gsi.gov.uk.
authors.forename: J
authors.initials: J
authors.lastname: Blenkinsop
mesh_terms: D000818:Animals; D006801:Humans; D011358:Product Surveillance, Postmarketing; D006113:United Kingdom; D019155:Veterinary Drugs / Q000009:adverse effects*; D014730:Veterinary Medicine
chemical_list: D019155:Veterinary Drugs